In the INSEMA analyze – a prospectively randomized research evaluating SLNE vs. no SLNE in patients with early invasive breast cancer (??5?cm, cN0) and breast-conserving therapy – knowledge onJust lately revealed systematic opinions are corresponding with toxicity facts of randomized trials with bevacizumab as well as chemotherapy. In an open-l